Tredan, O., Zelichov, O., Barbash, Z., Daitsh, Y., Birnbaum, L., Tarcic, G., . . . Ray-Coquard, I. L. (2018). 44PCorrelation between an automated functional assay that predicts targeted agent (TA) sensitivity and the tumor response of the sorafenib treatment evaluated within the MOST clinical trial. Annals of Oncology, 29, N.PAG. https://doi.org/10.1093/annonc/mdy318.025
Chicago Style (17th ed.) CitationTredan, O., et al. "44PCorrelation Between an Automated Functional Assay That Predicts Targeted Agent (TA) Sensitivity and the Tumor Response of the Sorafenib Treatment Evaluated Within the MOST Clinical Trial." Annals of Oncology 29 (2018): N.PAG. https://doi.org/10.1093/annonc/mdy318.025.
MLA (9th ed.) CitationTredan, O., et al. "44PCorrelation Between an Automated Functional Assay That Predicts Targeted Agent (TA) Sensitivity and the Tumor Response of the Sorafenib Treatment Evaluated Within the MOST Clinical Trial." Annals of Oncology, vol. 29, 2018, p. N.PAG, https://doi.org/10.1093/annonc/mdy318.025.